Drug screening identifies Src/Abl inhibitor dasatinib as suppressor of IL-23 signaling in skin inflammation

Authors:

Abstract
No abstract available
All Related Versions
Funding Information
  • Centro de Biología Molecular Severo Ochoa
  • Centro Nacional de Biotecnología